CompletedNot Applicable

Preliminary Study Concerning the Validity of Parathyroid Exploration on a CZT Camera

France45 participantsStarted 2014-09-04

Plain-language summary

The goal of this study is to assess the performance of parathyroid imaging on a cardiac-dedicated CZT camera, compared to planar pinhole imaging, in patients referred for primary hyperparathyroidism.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * suffering from sporadic primary hyperparathyroidism * referred to the Nuclear Medicine Dept for a pre-operative scintigraphy of the parathyroid glands * who have given their written consent * who benefit from the French Government Medical Insurance Exclusion Criteria: * pregnant women * ages \< 18 or \> 80 years * hyperparathyroidism recidive after a first surgery * secondary or tertiary hyperparathyroidism * Multiple endocrine Neoplasia (MEN) type I context or familial history of hyperparathyroidism * absence of written consent * non-beneficiary of the French Government Medical Insurance

What they're measuring

Comparison of pathologic parathyroid detection performances between planar pinhole on Anger camera and tomoscintigraphy on CZT camera, gold standard being the pathological results after surgery

Timeframe: 6 months

Trial details

NCT IDNCT02854345

SponsorCentre Hospitalier Universitaire de Besancon

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-09-09

View on ClinicalTrials.gov More Primary Hyperparathyroidism trials